Screener
Roivant Sciences ROIV Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Roivant Sciences’s reported figures.
Based on trailing twelve months.
The source filing: Roivant Sciences’s 10-Q, filed February 6, 2026. Open the filing →
- Filed
- Feb 6, 2026, 7:31 AM EST
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q4 2025
- Accession
- 0001635088-26-000011
FAQ
- What is Roivant Sciences's return on equity?
- Roivant Sciences (ROIV) reported return on equity of -17.1% in Q4 2025.
- How has Roivant Sciences's return on equity changed year-over-year?
- Roivant Sciences's return on equity decreased by 2897.7% year-over-year, from 0.6% to -17.1%.
- What is the long-term trend for Roivant Sciences's return on equity?
- Over 4 years (2020 to 2024), Roivant Sciences's return on equity has grown at a -47.2% compound annual growth rate (CAGR), from -41.7% to -3.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Roivant Sciences's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude